BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 25367939)

  • 1. The NOTCH pathway plays a tumor suppressive role in bladder cancer.
    Cancer Discov; 2014 Nov; 4(11):1252. PubMed ID: 25367939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NOTCH pathway inactivation promotes bladder cancer progression.
    Maraver A; Fernandez-Marcos PJ; Cash TP; Mendez-Pertuz M; Dueñas M; Maietta P; Martinelli P; Muñoz-Martin M; Martínez-Fernández M; Cañamero M; Roncador G; Martinez-Torrecuadrada JL; Grivas D; de la Pompa JL; Valencia A; Paramio JM; Real FX; Serrano M
    J Clin Invest; 2015 Feb; 125(2):824-30. PubMed ID: 25574842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Notch-1 regulates proliferation and differentiation of human bladder cancer cell lines by inhibiting expression of Krüppel-like factor 4.
    Ai X; Jia Z; Liu S; Wang J; Zhang X
    Oncol Rep; 2014 Oct; 32(4):1459-64. PubMed ID: 25109409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bladder cancer and the Notch pathway.
    Fernandez-Marcos PJ; Serrano M; Maraver A
    Oncotarget; 2015 Jan; 6(3):1346-7. PubMed ID: 25633811
    [No Abstract]   [Full Text] [Related]  

  • 5. A new tumor suppressor role for the Notch pathway in bladder cancer.
    Rampias T; Vgenopoulou P; Avgeris M; Polyzos A; Stravodimos K; Valavanis C; Scorilas A; Klinakis A
    Nat Med; 2014 Oct; 20(10):1199-205. PubMed ID: 25194568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unravelling disparate roles of NOTCH in bladder cancer.
    Goriki A; Seiler R; Wyatt AW; Contreras-Sanz A; Bhat A; Matsubara A; Hayashi T; Black PC
    Nat Rev Urol; 2018 Jun; 15(6):345-357. PubMed ID: 29643502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in FGFR3 and PIK3CA, singly or combined with RAS and AKT1, are associated with AKT but not with MAPK pathway activation in urothelial bladder cancer.
    Juanpere N; Agell L; Lorenzo M; de Muga S; López-Vilaró L; Murillo R; Mojal S; Serrano S; Lorente JA; Lloreta J; Hernández S
    Hum Pathol; 2012 Oct; 43(10):1573-82. PubMed ID: 22417847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular pathology of low malignant bladder transitional cell carcinoma: a current perspective.
    Wang HT; Chang JW
    Histol Histopathol; 2005 Jan; 20(1):147-53. PubMed ID: 15578434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NOTCH1 and NOTCH2 regulate epithelial cell proliferation in mouse and human gastric corpus.
    Demitrack ES; Gifford GB; Keeley TM; Horita N; Todisco A; Turgeon DK; Siebel CW; Samuelson LC
    Am J Physiol Gastrointest Liver Physiol; 2017 Feb; 312(2):G133-G144. PubMed ID: 27932500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Not all NOTCH Is Created Equal: The Oncogenic Role of NOTCH2 in Bladder Cancer and Its Implications for Targeted Therapy.
    Hayashi T; Gust KM; Wyatt AW; Goriki A; Jäger W; Awrey S; Li N; Oo HZ; Altamirano-Dimas M; Buttyan R; Fazli L; Matsubara A; Black PC
    Clin Cancer Res; 2016 Jun; 22(12):2981-92. PubMed ID: 26769750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver-specific inactivation of Notch2, but not Notch1, compromises intrahepatic bile duct development in mice.
    Geisler F; Nagl F; Mazur PK; Lee M; Zimber-Strobl U; Strobl LJ; Radtke F; Schmid RM; Siveke JT
    Hepatology; 2008 Aug; 48(2):607-16. PubMed ID: 18666240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical applications of molecular biomarkers in urothelial carcinoma of bladder].
    Cheng L; Xu JW; He JJ; Zhao J; Teng XD
    Zhonghua Bing Li Xue Za Zhi; 2011 Oct; 40(10):714-7. PubMed ID: 22321559
    [No Abstract]   [Full Text] [Related]  

  • 13. Notch1 and Notch2 receptors influence progressive hair graying in a dose-dependent manner.
    Schouwey K; Delmas V; Larue L; Zimber-Strobl U; Strobl LJ; Radtke F; Beermann F
    Dev Dyn; 2007 Jan; 236(1):282-9. PubMed ID: 17080428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Both Notch1 and Notch2 contribute to the regulation of melanocyte homeostasis.
    Kumano K; Masuda S; Sata M; Saito T; Lee SY; Sakata-Yanagimoto M; Tomita T; Iwatsubo T; Natsugari H; Kurokawa M; Ogawa S; Chiba S
    Pigment Cell Melanoma Res; 2008 Feb; 21(1):70-8. PubMed ID: 18353145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical analysis of the role and relationship between Notch-1 and Oct-4 expression in urinary bladder carcinoma.
    Abdou AG; El-Wahed MM; Kandil MA; Samaka RM; Elkady N
    APMIS; 2013 Oct; 121(10):982-96. PubMed ID: 23594289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NOTCH knockdown affects the proliferation and mTOR signaling of leukemia cells.
    Okuhashi Y; Itoh M; Nara N; Tohda S
    Anticancer Res; 2013 Oct; 33(10):4293-8. PubMed ID: 24122995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The different role of Notch1 and Notch2 in astrocytic gliomas.
    Xu P; Zhang A; Jiang R; Qiu M; Kang C; Jia Z; Wang G; Han L; Fan X; Pu P
    PLoS One; 2013; 8(1):e53654. PubMed ID: 23349727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/beta-catenin signaling pathway.
    Urakami S; Shiina H; Enokida H; Kawakami T; Tokizane T; Ogishima T; Tanaka Y; Li LC; Ribeiro-Filho LA; Terashima M; Kikuno N; Adachi H; Yoneda T; Kishi H; Shigeno K; Konety BR; Igawa M; Dahiya R
    Clin Cancer Res; 2006 Jan; 12(2):383-91. PubMed ID: 16428476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transgenic expression of Notch in melanocytes demonstrates RBP-Jkappa-dependent signaling.
    Schouwey K; Larue L; Radtke F; Delmas V; Beermann F
    Pigment Cell Melanoma Res; 2010 Feb; 23(1):134-6. PubMed ID: 19895548
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasticity in the Absence of NOTCH Uncovers a RUNX2-Dependent Pathway in Small Cell Lung Cancer.
    Hong D; Knelson EH; Li Y; Durmaz YT; Gao W; Walton E; Vajdi A; Thai T; Sticco-Ivins M; Sabet AH; Jones KL; Schinzel AC; Bronson RT; Nguyen QD; Tolstorukov MY; Vivero M; Signoretti S; Barbie DA; Oser MG
    Cancer Res; 2022 Jan; 82(2):248-263. PubMed ID: 34810201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.